title: Serum Strongylus vulgaris-specific antibody responses to anthelmintic treatment in naturally infected horses.
abstract: Strongylus vulgaris is the most pathogenic helminth parasite of horses, causing verminous endarteritis with thromboembolism and infarction. A serum enzyme-linked immunosorbent assay (ELISA) has been validated for detection of antibodies to an antigen produced by migrating larvae of this parasite. The aim was to evaluate ELISA responses to anthelmintic treatment in cohorts of naturally infected horses. Fifteen healthy horses harboring patent S. vulgaris infections were turned out for communal grazing in May 2013 (day 0). On day 55, horses were ranked according to ELISA titers and randomly allocated to the following three groups: no treatment followed by placebo pellets daily; ivermectin on day 60 followed by placebo pellets daily; or ivermectin on day 60 followed by daily pyrantel tartrate. Fecal and serum samples were collected at ∼28-day intervals until study termination on day 231. Increased ELISA values were observed for the first 53 days following ivermectin treatment. Titers were significantly reduced 80 days after ivermectin treatment. Horses receiving daily pyrantel tartrate maintained lower ELISA values from 137 days post ivermectin treatment until trial termination. These results illustrate that a positive ELISA result is indicative of either current or prior exposure to larval S. vulgaris infection within the previous 5 months.
authors.affiliation: M.H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY, USA, martin.nielsen@uky.edu.
authors.forename: Martin K
authors.initials: MK
authors.lastname: Nielsen
authors.forename: Anand N
authors.initials: AN
authors.lastname: Vidyashankar
authors.forename: Jennifer
authors.initials: J
authors.lastname: Bellaw
authors.forename: Holli S
authors.initials: HS
authors.lastname: Gravatte
authors.forename: Xin
authors.initials: X
authors.lastname: Cao
authors.forename: Emily F
authors.initials: EF
authors.lastname: Rubinson
authors.forename: Craig R
authors.initials: CR
authors.lastname: Reinemeyer
mesh_terms: D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D000909:Antibodies, Helminth / Q000097:blood*; D015331:Cohort Studies; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D005243:Feces / Q000469:parasitology; D006734:Horse Diseases / Q000188:drug therapy* / Q000276:immunology / Q000469:parasitology; D006736:Horses; D007559:Ivermectin / Q000627:therapeutic use*; D007814:Larva; D010270:Parasite Egg Count / Q000662:veterinary; D011897:Random Allocation; D017206:Strongylida Infections / Q000188:drug therapy / Q000276:immunology / Q000469:parasitology / Q000662:veterinary*; D013323:Strongylus / Q000187:drug effects / Q000276:immunology*
chemical_list: D000871:Anthelmintics; D000909:Antibodies, Helminth; D007559:Ivermectin